Last Updated: June 11, 2026

FLUVOXAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Fluvoxamine patents expire, and what generic alternatives are available?

Fluvoxamine is a drug marketed by Actavis Elizabeth, Ajanta Pharma Ltd, Annora Pharma, Appco, Bionpharma, Ph Health, Torrent, Aiping Pharm Inc, Ani Pharms, Apotex, Chartwell Rx, Heritage Pharma, Mylan, Quagen, Sun Pharm Industries, Synthon Pharms, Teva, and Upsher Smith Labs. and is included in twenty-one NDAs.

The generic ingredient in FLUVOXAMINE is fluvoxamine maleate. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fluvoxamine

A generic version of FLUVOXAMINE was approved as fluvoxamine maleate by AIPING PHARM INC on November 29th, 2000.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for FLUVOXAMINE?
  • What are the global sales for FLUVOXAMINE?
  • What is Average Wholesale Price for FLUVOXAMINE?
Summary for FLUVOXAMINE
US Patents:0
Applicants:18
NDAs:21
Drug Prices: Drug price information for FLUVOXAMINE
DailyMed Link:FLUVOXAMINE at DailyMed

US Patents and Regulatory Information for FLUVOXAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quagen FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075889-001 Nov 29, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Bionpharma FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 217917-003 Jan 22, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Synthon Pharms FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075899-003 Jan 17, 2001 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 076125-002 Apr 29, 2002 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva FLUVOXAMINE MALEATE fluvoxamine maleate TABLET;ORAL 075893-001 Sep 10, 2002 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.